14-day Premium Trial Subscription Try For FreeTry Free
FRA:BV3
Delisted

Bavarian Nordic A/S Stock Price (Quote)

Frankfurt Stock Exchange
Open Broker Account
20.64€
+0 (+0%)
At Close: Dec 22, 2023
Forecast Insider Trading Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days 20.64€ 20.64€ Friday, 22nd Dec 2023 BV3.F stock ended at 20.64€. During the day the stock fluctuated 0% from a day low at 20.64€ to a day high of 20.64€.
90 days 20.18€ 21.17€
52 weeks 18.20€ 35.60€

Historical Bavarian Nordic A/S prices

Date Open High Low Close Volume
Apr 20, 2023 25.19€ 25.21€ 25.19€ 25.21€ 0
Apr 19, 2023 24.61€ 25.24€ 24.61€ 25.24€ 0
Apr 18, 2023 26.32€ 26.32€ 24.98€ 24.98€ 0
Apr 17, 2023 26.95€ 26.95€ 25.97€ 25.97€ 0
Apr 14, 2023 27.22€ 27.22€ 26.61€ 26.63€ 0
Apr 13, 2023 27.15€ 27.15€ 27.15€ 27.15€ 0
Apr 12, 2023 27.50€ 27.50€ 27.50€ 27.50€ 0
Apr 11, 2023 26.80€ 26.90€ 26.80€ 26.90€ 0
Apr 06, 2023 25.99€ 25.99€ 25.82€ 25.82€ 5
Apr 05, 2023 26.35€ 26.35€ 26.35€ 26.35€ 0
Apr 04, 2023 25.96€ 26.35€ 25.96€ 26.35€ 0
Apr 03, 2023 26.08€ 26.08€ 25.71€ 25.71€ 0
Mar 31, 2023 26.69€ 26.69€ 26.02€ 26.02€ 0
Mar 30, 2023 26.41€ 26.41€ 26.41€ 26.41€ 0
Mar 29, 2023 24.71€ 26.34€ 24.71€ 26.34€ 0
Mar 28, 2023 25.05€ 25.05€ 24.67€ 24.67€ 0
Mar 27, 2023 25.12€ 25.20€ 25.12€ 25.20€ 5
Mar 24, 2023 24.29€ 24.32€ 24.29€ 24.32€ 0
Mar 23, 2023 24.25€ 24.25€ 24.25€ 24.25€ 0
Mar 22, 2023 24.70€ 24.70€ 24.70€ 24.70€ 0
Mar 21, 2023 24.03€ 24.49€ 24.03€ 24.49€ 0
Mar 20, 2023 22.98€ 22.98€ 22.98€ 22.98€ 0
Mar 17, 2023 24.53€ 24.53€ 24.53€ 24.53€ 0
Mar 16, 2023 24.64€ 24.64€ 24.08€ 24.32€ 0
Mar 15, 2023 25.83€ 25.83€ 24.50€ 24.50€ 0
Click to get the best stock tips daily for free!

About Bavarian Nordic A/S

Bavarian Nordic A/S Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,... BV3.F Profile

Golden Star

Ticker Date Change Price
BSCQ Apr 30 0.393% $19.09
EQC Apr 30 1.76% $18.72
HRB Apr 30 1.69% $47.23
REG Apr 30 1.35% $59.22
INGR Apr 30 0.576% $114.59
BSJP Apr 29 0.175% $22.91
LYG Apr 29 0.781% $2.56
ORA Apr 29 3.46% $64.48
DHT Apr 24 4.34% $11.28
LPLA Apr 19 2.62% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT